Abstract Number: 901 • 2014 ACR/ARHP Annual Meeting
Rate of Serum Uric Acid (SUA) Assessment in Gout Patients Treated with Urate-Lowering Therapy: Treating to Target?
Background/Purpose: Gout is the most common form of inflammatory arthritis and is caused by chronic hyperuricemia, leading to urate crystal deposition disease and subsequent intermittent…Abstract Number: 900 • 2014 ACR/ARHP Annual Meeting
Race and Sex Specific Incidence Rates and Predictors of Total Knee Arthroplasty: Data from the Osteoarthritis Initiative, 7 Years Follow up
Background/Purpose: Total knee arthroplasty (TKA) is used to reduce pain and improve functional status in persons with symptomatic knee osteoarthritis (OA). Several studies point to…Abstract Number: 919 • 2014 ACR/ARHP Annual Meeting
Glucocorticoid Exposure and Fracture Risk in a Large Cohort of Commercially-Insured Rheumatoid Arthritis Patients Under Age 65
Background/Purpose Systemic glucocorticoid use can increase fracture risk, although dose-specific effects are not well understood, especially in younger adults. Underlying diseases (e.g., rheumatoid arthritis [RA])…Abstract Number: 918 • 2014 ACR/ARHP Annual Meeting
Findings from Denosumab (Prolia®) Postmarketing Safety Surveillance for Serious Infections
Background/Purpose: Prolia has marketing authorization in the EU, US, Canada, Japan, and over 40 countries or administrative districts worldwide for the treatment of postmenopausal women…Abstract Number: 917 • 2014 ACR/ARHP Annual Meeting
Evaluation of Invasive Oral Procedures and Events in Women with Postmenopausal Osteoporosis Treated with Denosumab: Results from the Pivotal Phase 3 Fracture Study Extension
Background/Purpose: Osteonecrosis of the jaw (ONJ) is a rare but serious adverse event of some antiresorptive therapies, including denosumab (DMAb), and invasive oral procedures and…Abstract Number: 916 • 2014 ACR/ARHP Annual Meeting
Effects of 2 Years of Treatment with Romosozumab Followed By 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density
Background/Purpose: We previously reported that 1 year of treatment with the sclerostin antibody romosozumab (Romo) was associated with increased bone mineral density (BMD) and bone…Abstract Number: 914 • 2014 ACR/ARHP Annual Meeting
A Predictive Model of Disease Outcome in Rituximab-Treated Myositis Patients Using Clinical Features, Autoantibodies, and Serum Biomarkers
Background/Purpose: Develop predictive models of early (8 week) and late (24 week) disease outcomes using clinical features, autoantibodies, and serum biomarkers in patients with refractory…Abstract Number: 913 • 2014 ACR/ARHP Annual Meeting
Long Term Outcomes of Patients with Moderate Creatine Kinase (CK) Elevation Seen in a Rheumatology Clinic
Background/Purpose: Asymptomatic or mildly symptomatic patients with moderate creatine kinase (CK) elevation are commonly referred to rheumatologists. In patients without a clearly established diagnosis, the…Abstract Number: 915 • 2014 ACR/ARHP Annual Meeting
Increased Risk of Myocardial Infarction in Dermatomyositis and Polymyositis: A General Population-Based Cohort Study
Background/Purpose Patients with polymyositis (PM) and dermatomyositis (DM) may have an increased risk of myocardial infarction (MI), similar to other connective tissue diseases. However, no…Abstract Number: 897 • 2014 ACR/ARHP Annual Meeting
Resting State Functional Connectivity Differs Between Chronic Fatigue Syndrome Patients and Healthy Controls
Background/Purpose: Examining neural activity in the absence of task (i.e. resting state) is an active area of research. Functional connectivity, defined as correlations in BOLD…Abstract Number: 893 • 2014 ACR/ARHP Annual Meeting
Polysymptomatic Distress Categories for Clinical and Research Use
Background/Purpose: The polysymptomatic distress (PSD) scale is derived from variables used in the 2010 American College of Rheumatology (ACR) fibromyalgia (FM) criteria as modified for…Abstract Number: 894 • 2014 ACR/ARHP Annual Meeting
Small Fiber Neuropathy in Women with Fibromyalgia. a Clinical-Pathological Correlation Using Confocal Corneal Biomicroscopy
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome (Semin Arthritis Rheum 2000;29:197). This view has been recently reinforced…Abstract Number: 895 • 2014 ACR/ARHP Annual Meeting
The Fibromyalgia Syndrome and Widespread Pain Frequency in Active Duty U.S. Service Members with Posttraumatic Stress Disorder
Background/Purpose: Posttraumatic stress disorder (PTSD) and pain are common amongst US military service members who have deployed to Iraq and Afghanistan. Studies suggest the co-morbidity…Abstract Number: 896 • 2014 ACR/ARHP Annual Meeting
Development of Fibromyalgia and Polysymptomatic Distress Definitions in the National Health Interview Survey
Background/Purpose: A detailed understanding of fibromyalgia and its symptoms in the US population would be valuable. The National Health Interview Survey (NHIS) is the principal…Abstract Number: 892 • 2014 ACR/ARHP Annual Meeting
Symptom Increase in Fibromyalgia Is Not Consistent with the Central Sensitization or Central Hyperresponsiveness Hypothesis
Background/Purpose: The current dominant hypothesis explains fibromyalgia (FM) as a centralized pain state in which the CNS originates or amplifies pain, which is then accompanied…
ACR Meeting Abstracts